Chinas COVID vaccine shows no side effects in Russian trials
2020-09-24 17:25
BEIJING  Chinas candidate coronavirus vaccine caused no side effects among recruits in Moscow as part of largescale clinical trials, reported Russian Englishlanguage newspaper The Moscow Times.Russia approved Phase  trials of the Chinese vaccine developed by CanSino Biologics, a Chinese hightech biopharmaceutical company, and a research team with the Academy of Military Sciences last month.At the moment, the volunteers are doing well. None of them have shown any side effects, Petrovax, the Russian pharmaceutical company working with the vaccines Chinese developers, announced Monday in a press release.Petrovax said it has received more than , applications to get the AdnCoV vaccine so far.The studys participants will be under direct supervision for nearly a month, with four interim facetoface examinations, and will undergo a control examination after six months, Petrovax said.The Russian company said it expects preliminary results sometime in November, according to the Interfax news agency.Once Russia registers the Chinese vaccine, Petrovax said it will be able to produce more than  million doses per month this year and  million doses per month in .China is actively conducting international cooperation on the development of drugs and vaccines against COVID.CanSino announced plans last month to launch Phase  trials of the vaccine in Saudi Arabia involving about , subjects.